Recent studies have begun to characterize the actions of stress and antidepressant
treatments beyond the neurotransmitter and receptor level. This work has demonstrated that …

The 1950s saw the clinical introduction of the first two specifically antidepressant drugs:
iproniazid, a monoamine-oxidase inhibitor that had been used in the treatment of …

Elderly people are more likely than younger patients to develop cognitive impairment as a
result of taking medications. This reflects age-and disease-associated changes in brain …

Welcome to the fifth edition of a very handy and useful book, the Manual of Clinical
Psychopharmacology. Readers familiar with any of the previous editions are already aware …

Sleep is an essential component of healthy development and is required for physical and
mental health. Sleep deprivation and sleep disorders are highly prevalent among Canadian …

Organic delusions are common, but have received little systematic study. Review of the
literature reveals that they occur most commonly in toxicmetabolic processes and in …

Objective To test the hypothesis that sleep-related breathing disorder (SRBD) is associated
with poor blood pressure control in hypertensive patients independent from confounding …

This study aimed to investigate the association between cardiovascular drugs and
depression/anxiety in patients with cardiovascular disease (CVD). This meta-analysis was …

Little information exists on the epidemiology of central nervous system side effects in
patients taking antihypertensive medications. We examined prevalence rates of tricyclic …

In this study, pharmacophore based 3D QSAR models for human acetylcholinesterase
(AChE) inhibitors were generated, with good significance, statistical values (r2training …